Keyphrases
Clinical Significance
100%
Amyotrophic Lateral Sclerosis
100%
Mutation Carriers
100%
Single Subject
100%
Hypometabolism
100%
Brain Metabolism
100%
18F-fluorodeoxyglucose PET
55%
Gene mutation
44%
ALS Patients
44%
Brain Hypometabolism
44%
C9orf72
33%
Superoxide Dismutase 1 (SOD1)
22%
TANK-binding Kinase 1 (TBK1)
22%
Slow Progressor
22%
Fast Progressors
22%
Subject-level
22%
KIF5A
22%
Statistical Parametric Mapping
22%
Italy
11%
Novel Biomarkers
11%
Clinical Features
11%
Metabolism
11%
Disease Progression
11%
Clinical Data
11%
Strong Correlation
11%
Tertiary Care Hospital
11%
Genotype-phenotype Correlation
11%
Clinical Evaluation
11%
Motor Area
11%
Motor Cortex
11%
Clinical Examination
11%
Symptom Onset
11%
Familial ALS
11%
Neuropsychological Assessment
11%
Diagnostic Work-up
11%
Neuronal Dysfunction
11%
PET Scan
11%
Motor Impairment
11%
High Heterogeneity
11%
Limbic Regions
11%
Limbic System
11%
Mapping Method
11%
New Diagnostic Method
11%
ALS Gene
11%
Integrative Approach
11%
Neuropsychological Data
11%
Single-subject Analysis
11%
Clinical Impairment
11%
Voxel-based
11%
Neuropsychological Impairment
11%
Neuropsychological Features
11%
Pathogenic Genes
11%
Group Data Sharing
11%
Neuropsychological Performance
11%
Motor Involvement
11%
Biochemistry, Genetics and Molecular Biology
Gene Mutation
100%
Brain Metabolism
100%
C9orf72
75%
Genetics
50%
SOD1
50%
Imaging Software
50%
KIF5A
50%
Metabolic Pathway
25%
Genotype Phenotype Correlation
25%
Positron Emission Tomography
25%